BridgeBio Historical Valuation
| BBIO Stock | USD 35.97 1.76 5.14% |
Some fundamental drivers such as market cap or BridgeBio Pharma enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze BridgeBio Pharma valuation indicators such as Working Capital of 0.0 or Enterprise Value of 7.5 B to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of BridgeBio Pharma's future value.
BridgeBio |
About BridgeBio Valuation Data Analysis
Valuation is the financial process of determining what BridgeBio Pharma is worth. BridgeBio Pharma valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. BridgeBio Pharma valuation ratios help investors to determine whether BridgeBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BridgeBio with respect to the benefits of owning BridgeBio Pharma security.
BridgeBio Pharma Valuation Data Chart
Enterprise Value
Enterprise Value (or EV) is usually referred to as BridgeBio Pharma theoretical takeover price. In the event of an acquisition, an acquirer would have to take on BridgeBio Pharma debt, but would also pocket its cash. Enterprise Value is more accurate representation of BridgeBio Pharma value than its market capitalization because it takes into account all of BridgeBio Pharma existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Pair Trading with BridgeBio Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BridgeBio Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against BridgeBio Stock
| 0.77 | NHC | National HealthCare | PairCorr |
| 0.74 | DERM | Journey Medical Corp Upward Rally | PairCorr |
| 0.67 | INNV | InnovAge Holding Corp Earnings Call This Week | PairCorr |
| 0.63 | PNTG | Pennant Group | PairCorr |
| 0.62 | UPC | Universe Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to BridgeBio Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BridgeBio Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BridgeBio Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BridgeBio Pharma to buy it.
The correlation of BridgeBio Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BridgeBio Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BridgeBio Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BridgeBio Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BridgeBio Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BridgeBio Pharma. If investors know BridgeBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BridgeBio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
The market value of BridgeBio Pharma is measured differently than its book value, which is the value of BridgeBio that is recorded on the company's balance sheet. Investors also form their own opinion of BridgeBio Pharma's value that differs from its market value or its book value, called intrinsic value, which is BridgeBio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BridgeBio Pharma's market value can be influenced by many factors that don't directly affect BridgeBio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BridgeBio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if BridgeBio Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BridgeBio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.